Pharma BD Deal Intelligence

Dainippon Sumitomo Pharma Co., Ltd. / Sepracor Inc.

2009 · Acquisition/Merger · $2.6B · Complete

Announcement Sentiment
75
Strongly positive

$23/share = ~$2.6B cash tender. CNS/respiratory specialty pharma (Lunesta, Xopenex). Closed Oct 20, 2009. Source: Sumitomo Pharma news, WilmerHale, Bloomberg.

Key facts

See the full interactive analysis, sources & comparables →